Table 5 Failure pattern and dosimetric characteristics in patients with nodal recurrence
Patient nº | Localization nodal failure | XRT volume | Failure (month) | Volume (cc) | Minimum dose (cGy) | Maximum dose (cGy) | Mean dose (cGy) |
|---|---|---|---|---|---|---|---|
1 | II-III ipsilateral | Nodal CTV2 | 6 | 9.1 | 6498.2 | 6980.0 | 6602.9 |
2 | III-IV ipsilateral | Nodal CTV2 | 12 | 3.45 | 6489.9 | 6995.9 | 6629.5 |
3 | II ipsilateral | Nodal CTV1 | 14 | 2.8 | 4399.0 | 6551.2 | 5554.1 |
(Nodal CTV2 marginal) | |||||||
4 | III ipsilateral | Nodal CTV0 | 9 | 9.35 | 175.1 | 3113.2 | 1191.4 |
5 | III ipsilateral | Nodal CTV1 | 8 | 1.83 | 5685.5 | 7005.2 | 6535.1 |
II ipsilateral | Nodal CTV2 | 8 | 2.51 | 6652.8 | 6741.6 | 6701.8 | |
6 | II ipsilateral | Nodal CTV2 | 7 | 3.5 | 7009.1 | 7255.1 | 7149.8 |
7 | V ipsilateral | Nodal CTV0 | 19 | 3.1 | 195.0 | 5050.1 | 2789.8 |
8 | Ib-II ipsilateral | Nodal CTV2 | 8 | 3.35 | 6561.1 | 7171.2 | 6805.5 |
9 | II-III ipsilateral | Nodal CTV0 | 17 | 2.9 | 589.9 | 5101.0 | 3091.0 |
(nodal CTV1 marginal) | |||||||
10 | Ib ipsilateral | Nodal CTV1 | 11 | 2.8 | 6491.0 | 7001.0 | 6682.2 |
II ipsilateral | Nodal CTV2 | 11 | 1.9 | 4901.0 | 6281.2 | 5402.3 | |
11 | II ipsilateral | Nodal CTV2 | 7 | 9.8 | 6595.3 | 6798.4 | 6639.0 |
12 | Ib ipsilateral | Nodal CTV2 | 7 | 2.9 | 6598.2 | 6792.0 | 6689.3 |
13 | II ipsilateral | Nodal CTV2 | 8 | 2.1 | 6601.4 | 6850.1 | 6602.2 |
14 | Ib ipsilateral | Nodal CTV2 | 11 | 2.8 | 6599.0 | 6899.4 | 6598.0 |
15 | Ib ipsilateral | Nodal CTV2 | 10 | 10.2 | 6278.7 | 7195.5 | 6658.9 |